Early tolerance and late persistence as alternative drug responses in cancerSimona Punzi, Giovanni Tonon, Oronza A. Botrugno et al.|Nature Communications|2025Cited by 11
Defining evolutionary trajectories in myelodysplastic syndromes and integrating them into prognostic models to improve risk stratification: The progevo machine learning approachIvan Civettini, Daniele Ramazzotti, Federica Malighetti et al.|Blood|2025Cited by 0